Recursion Pharmaceuticals Inc. (RXRX): Price and Financial Metrics
RXRX Price/Volume Stats
| Current price | $5.28 | 52-week high | $12.36 |
| Prev. close | $5.72 | 52-week low | $3.79 |
| Day low | $5.25 | Volume | 31,616,100 |
| Day high | $5.61 | Avg. volume | 24,748,076 |
| 50-day MA | $4.86 | Dividend yield | N/A |
| 200-day MA | $6.28 | Market Cap | 2.15B |
RXRX Stock Price Chart Interactive Chart >
Recursion Pharmaceuticals Inc. (RXRX) Company Bio
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people’s lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.
RXRX Price Returns
| 1-mo | 7.32% |
| 3-mo | -6.38% |
| 6-mo | -17.76% |
| 1-year | -36.84% |
| 3-year | -37.88% |
| 5-year | N/A |
| YTD | -21.89% |
| 2024 | -31.44% |
| 2023 | 27.89% |
| 2022 | -54.99% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...